Literature DB >> 977399

Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.

J F Fowler, P W Sheldon, J Denekamp, S B Field.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 977399     DOI： 10.1016/0360-3016(76)90139-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

1.  Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.

Authors:  H D Kogelnik; J H Meyer; K Jentzsch; T Szepesi; K H Kärcher; E Maida; B Mamoli; P Wessely; F Zaunbauer
Journal:  Br J Cancer Suppl       Date:  1978-06

2.  Sensitization of mouse tumours using fractionated X-irradiation.

Authors:  J Denekamp; F A Stewart
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 3.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Authors:  J Martin Brown; David J Carlson; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

Review 4.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

Authors:  J Martin Brown; Maximilian Diehn; Billy W Loo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

6.  A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).

Authors:  E K Reddy
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.

Authors:  Olivia J Kelada; Roy H Decker; Sameer K Nath; Kimberly L Johung; Ming-Qiang Zheng; Yiyun Huang; Jean-Dominique Gallezot; Chi Liu; Richard E Carson; Uwe Oelfke; David J Carlson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

8.  A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.

Authors:  R P Abratt
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

9.  Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.

Authors:  Eric Leung; Rob A Cairns; Naz Chaudary; Ravi N Vellanki; Tuula Kalliomaki; Eduardo H Moriyama; Hilda Mujcic; Brian C Wilson; Bradly G Wouters; Richard Hill; Michael Milosevic
Journal:  BMC Cancer       Date:  2017-06-15       Impact factor: 4.430

10.  A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.

Authors:  R P Abratt; P Craighead; V B Reddi; L A Sarembock
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.